Literature DB >> 25319221

TRIM family proteins: emerging class of RING E3 ligases as regulator of NF-κB pathway.

Dhanendra Tomar1, Rajesh Singh.   

Abstract

The nuclear factor κB (NF-κB) transcription factor family plays a key role in regulation of the inflammatory pathway in response to different physiological stimuli starting from development to ageing. The dysregulation of NF-κB has been associated with many pathological conditions like inflammatory diseases, neurodegeneration, metabolic diseases and various kinds of malignancies. The NF-κB pathway is regulated by number of post-translational modifications, including phosphorylation and ubiquitination. Ubiquitin (Ub) E3 ligases are key regulators of the process of ubiquitination and provide specificity to the pathway as they recognise the substrate and determine the topology of ubiquitination. TRIMs, members of RING family of Ub E3 ligases, are characterised by the presence of three conserved domains, RING, B-Box and coiled-coil (RBCC). Emerging evidence suggests that TRIMs regulate innate immune signalling during infection and different pathological conditions. The studies have demonstrated the role of TRIMs in regulation of inflammatory pathways including NF-κB. Recent reports suggest that TRIMs play a critical role in regulation of the NF-κB pathway by ubiquitinating proteins at different steps. In the current review, we discuss the role of TRIMs as novel NF-κB regulators and their role in different pathophysiological conditions.
© 2014 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NF-κB; RING E3 ligase; TRIM proteins; Ubiquitin E3 ligases; Ubiquitination

Mesh:

Substances:

Year:  2014        PMID: 25319221     DOI: 10.1111/boc.201400046

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  29 in total

Review 1.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

Review 2.  Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome.

Authors:  Michael G Kattah; Barbara A Malynn; Averil Ma
Journal:  J Mol Biol       Date:  2017-10-13       Impact factor: 5.469

3.  Inhibition of Macrophage Complement Receptor CRIg by TRIM72 Polarizes Innate Immunity of the Lung.

Authors:  Nagaraja Nagre; Xiaofei Cong; César Terrazas; Ian Pepper; John M Schreiber; Hongyun Fu; Joshua M Sill; John W Christman; Abhay R Satoskar; Xiaoli Zhao
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

4.  TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.

Authors:  Rui Pedro Galão; Harry Wilson; Kristina L Schierhorn; Franka Debeljak; Bianca S Bodmer; Daniel Goldhill; Thomas Hoenen; Sam J Wilson; Chad M Swanson; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 6.823

5.  Enrichment of Newly Synthesized Proteins following treatment of C2C12 Myotubes with Endotoxin and Interferon-γ.

Authors:  Catherine S Coleman; Bruce A Stanley; Charles H Lang
Journal:  Inflammation       Date:  2022-01-14       Impact factor: 4.657

6.  Trim27 interacts with Slx2, is associated with meiotic processes during spermatogenesis.

Authors:  Xin-Jie Zhuang; Wen-Hao Tang; Xue Feng; Chang-Yu Liu; Jin-Liang Zhu; Jie Yan; De-Feng Liu; Ping Liu; Jie Qiao
Journal:  Cell Cycle       Date:  2016-09-09       Impact factor: 4.534

7.  Genomic architecture of inflammatory bowel disease in five families with multiple affected individuals.

Authors:  Anna B Stittrich; Justin Ashworth; Mude Shi; Max Robinson; Denise Mauldin; Mary E Brunkow; Shameek Biswas; Jin-Man Kim; Ki-Sun Kwon; Jae U Jung; David Galas; Kyle Serikawa; Richard H Duerr; Stephen L Guthery; Jacques Peschon; Leroy Hood; Jared C Roach; Gustavo Glusman
Journal:  Hum Genome Var       Date:  2016-01-07

8.  miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.

Authors:  Tong Wang; Yipeng Ren; Ruixun Liu; Juntao Ma; Yueyi Shi; Lei Zhang; Rongfa Bu
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

Review 9.  Ubiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global Profiling.

Authors:  Claire E O'Leary; Emma L Lewis; Paula M Oliver
Journal:  Front Immunol       Date:  2015-12-16       Impact factor: 7.561

10.  TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.

Authors:  Hidetaka Kawabata; Kotaro Azuma; Kazuhiro Ikeda; Ikuko Sugitani; Keiichi Kinowaki; Takeshi Fujii; Akihiko Osaki; Toshiaki Saeki; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.